TrialESMO open2023

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial.

E Grassi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.